第十四届上海国际生物技术与医药研讨会最新日程公布

9:15am-9:20am

陈竺，中国卫生部部长

　

9:20am-9:25am

William Chin，哈佛大学医学院执行院长

　

9:25am-9:30am

　

9:30am-9:35am

LUC Montagnier   诺贝尔生理学或医学奖获得者（2008年），联合国教科文组织世界艾滋病研究与防治基金会主席

　

9:35am-9:45am

签约仪式

 

9:45am-10:15am

LUC Montagnier，诺贝尔生理学或医学奖获得者（2008年），联合国教科文组织世界艾滋病研究与防治基金会主席

　

10:15am-10:45am

William Chin，哈佛大学医学院执行院长

 

11:00am-11:30am

Stephen Friend，美国Sage Bionetworks研究中心

 

11:30am-12:00am

Garry Neil，美国强生公司副总裁

 

分会 1  主席：万昭奎，美国辉瑞 高级主任科学家；美中生物医学协会（CABA）

共同创建人，前任会长（2009-2010）     

2:00pm-2:30pm

Michael R. McGurk，美国飞翰律师事务所 剑桥办公室 管理合伙人

Identify and protect intellectual property in pharmaceutical process and formulation innovation

2:30pm-3:00pm

陈少羽，美国科文顿•柏灵律师事务所北京办公室 中国药品法律团队的总负责人

Regulatory and Legal Considerations for Pharmaceutical Companies to Succeed in the U.S. and China

3:00pm-3:30pm

张引，美国米.张.吴.律师事务所 所长、合伙人

IP/Legal Aspects of International Biopharma R&D Collaborations

3:50pm-4:20pm

Adam Powell ，美国 Payer+Provider公司 合伙人、总裁

Improving health in the 21st Century: An overview of key changes caused by the American and Chinese healthcare reforms

4:20pm-4:50pm

Wansheng Jerry Liu ，美国Fox Rothschild 律师事务所 专利律师

How Similar Is biosimilar? Introducing the newest draft Guidance on Biosimilar Product Development by the US FDA

4:50pm-5:20pm

Tong Zhang ，美国Fish & Richardson PC律师事务所 纽约办公室 律师 

The "America Invents Act": What you need to know

分会 2 共同主席： Mingde Xia，美国强生制药集团 (Johnson & Johnson) 国际科技合

作部资深总监

共同主席:  Min Chen，美国诺华公司高级科学家

2:00pm-2:30pm

Zheng Jiang，美国华盛顿大学医学院 副教授

Metabolic activation-based prediction of toxicity in drug development

2:30pm-3:00pm

Allen Reitz ，宾夕法尼亚州生物技术中心 药物研究所 CEO

New Approaches for the Treatment of Amyotrophic Lateral Sclerosis

3:00pm-3:30pm

Jean Wang，美国默克公司 高级主任研究员

Drug Product Development Challenges and Opportunities: Integrated Approach of Novel Formulations Technology

3:50pm-4:20pm

Jong yuh Cherng，台湾國立中正大學化生系 副教授

Enhancing and targeting gene delivery by influenza virus

4:20pm-4:50pm

Guiqiang Liang，美国 Novartis公司 高级研究员

Opportunity of PBPK Modeling and Simulation in Drug Discovery

4:50pm-5:20pm

Dai Weiguo，美国强生公司 药物产品发展部 科学总监

Room Temperature Stable Biological Products without cold chain--Progress, Challenges and Opportunities

5:20pm-5:50pm

Srinivas Rao， 美国NIH疫苗研究部实验动物部

 

分会 3 共同主席： Brian Rudkin，法国里昂高等师范大学 分子与细胞生物实验室主任; 华东师范大学 紫江学者

共同主席:  Cui Jisong，Hua Medicine公司副总裁

2:00pm-2:30pm

刘新垣，中国科学院院士，上海生命科学研究院，

上海生物化学与细胞生物学研究所

Cancer Targeting Gene-Viro-Therapy

2:30pm-3:00pm

Brian Rudkin，法国里昂高等师范大学 分子与细胞生物实验室主任;华东师范大学 紫江学者

Peptide aptamers: precision tools for early development of novel therapeutic compounds.

3:00pm-3:30pm

Serge Pampfer，比利时瓦隆地区生物技术孵化器  董事长

Building a successful cell therapy industry

3:50pm-4:20pm

Yulia Sidorova，芬兰赫尔辛基大学 生物技术研究所 博士后

SMALL MOLECULAR WEIGHT ARTEMIN MIMETIC FOR THE TREATMENT OF NEUROPATHIC PAIN

4:20pm-4:50pm

Bin Shi，美国默克公司 RNAi治疗部 高级生物学家

Challenges and Opportunities in the Development of siRNA Lipid Nanoparticles

4:50pm-5:20pm

Meng Xia，中国Transgene公司总经理

 

5:20pm-5:50pm

Raphael Anasthase，法国 BioTray公司国际业务经理

生物制品的研发与制造的挑战

分会 4  主席： David E. Golan, Professor and Dean for Graduate Education        and Global Education Programs, Harvard Medical School

2:00pm-3:30pm

William W. Chin ， Executive Dean for Research, Harvard Medical School

 

Lee M. Nadler， Professor and Dean for Clinical and Translational Research, Harvard Medical School

 

Stephen Friend, President，Sage Bionetworks, Former SVP of Merck and Head of Oncology

 

Winston Patrick Kuo,Director of Harvard Catalyst Laboratory for Innovative Translational Technologies, Harvard Medical School

 

Jiping Wang,Associate Director of Hepatobilliary Cancer Program, Division of Surgical Oncology at Brigham and Women’s Hospital, Harvard Medical School and the Gastrointestinal Cancer Treatment Center at Dana-Farber Cancer Institute

 

Vincent Lotteau， Co-Founder of the European Institute on Systems Biology and Medicine, France

 

4:00pm-5:30pm

共同主席：  Dr. Yonghao Gui, Vice President of Fudan University, Dean of Fudan University Shanghai Medical College

共同主席： Quoqiang Chen, Vice President of Jiaotong University, Dean of Jiaotong University Medical School

4:00pm-5:30pm

Xuetao Cao, Professor and President of

Chinese Academy of Medical Science

 

Yonghao Gui, Vice President of Fudan University, Dean of Fudan University Shanghai Medical College

 

Hongzhuan Chen，Professor and Vice Dean of Jiaotong University Medical School

 

Yizhun Zhu, Professor and Dean of Fudan University School of Pharmacy

 

 

 

共同主席： Stephen Friend, President, Sage Bionetworks, Former SVP of Merck and Head of Oncology

共同主席：Jason Gang Jin, CEO of ShanghaiBio Corporation, EVP of Shanghai Biochip

9:00am-10:30am

Jingwu Zang， Senior Vice President and Head of GSK R&D China

 

Bin Peng, Global Head, Oncology Tanslational Medicine China

 

 

Kerry Blanchard, Senior Vice President and Head, Eli Lilly China Drug Development, China

 

Bei Zhang, Vice President, and Head of Lilly R&D China

 

John Luk, Head of Oncology, Roche R&D China

 

Steve Yang, Vice President and Head of R&D, Asia and Emerging Markets, AstraZeneca

 

 

Nicholas C. Dracopoli,  Vice President and Head of Oncology Biomarkers, Janssen Research & Development, USA

 

Dayao Zhao,  Head of J&J R&D China

 

 

10:30am-11:00am

11:00am-12:30pm

 

主席：Sean Zhang,  Medical Director and liaison to BMS China R&D at Discovery, SAPA-GP Elect-President

Guoqing Cao, VP and Global Head of Discovery, Hengrui Pharmaceutical Global R&D

 

Peng  Wang, CSO of  Simcere Pharmaceutical

 

John V. Oyler, CEO of BeiGene

 

Yue Wang, PI of R&D, BeiGene

 

12:30pm-2:00 pm

主办： Fenglin Life Science Park

主席： Sophia Qian, Managing Director, Fenglin Life Science Park office

2:00 pm-3:30 pm

共同主席：Wenru Song, Head of Regional Oncology Development/Takeda Shanghai Development Center &Millennium: Takeda Oncology Company, USA

共同主席：Mao Mao, Research Fellow, Pfizer Worldwide Research and Development, USA

David A Flockhart, Chair of Indiana Institute for Personalized Medicine, Chair of Cancer Genomics and Professor of Medicine, Medical Genetics and Pharmacology, Director of Clinical Pharmacology, Indiana University School of Medicine in Indianapolis, USA

 

Wenru Song, Head of Regional Oncology Development/Takeda Shanghai Development Center &Millennium‘Takeda Oncology Company, USA

 

Mao Mao , Research Fellow, Pfizer Worldwide Research and Development, USA

 

Huichuan Sun , Professor of Zhongshan Hospital Liver Cancer Institute, Fudan University

 

Yidong Chen, Professor, Department of Epidemiology and Biostatistics, The University of Texas Health Science Center at San Antonio

 

3:30 pm-4:00 pm

4:00pm – 5:30 pm

共同主席： Jason Gang Jin, CEO of Shanghai Bio Corporation

共同主席： Harry Yang, CBA

Kelly Hong, General Manager of Affymetrix China

 

Yingshuang Chai, National Sales Leader, Clinical, East China Sr.District Manager，Molecular Cell Biology, Applied Biosystems, Part of Life Technologies

 

Hong Xie, General Manager, Sequenom China

 

Jason Gang Jin, CEO of ShanghaiBio Corporation

 

Hongyue Sun, VP of Operation Technology Platform, COO of Wuxi Genomic Center, Wuxi AppTec

 

Peter Yan,  Technical Program/Project Manager at Frederick National Laboratory for Cancer Research, NCI/NIH, USA

 

分会5  主席：  Zhiliang Wu，宾大医学院 应用基因学中心 主任

2:00pm-2:30pm

Marcia Levenstein，美国辉瑞公司 副总裁

Challenges and Opportunities in Drug Development for Rare Diseases　

2:30pm-3:00pm

Zhiliang Wu，宾大医学院 应用基因学中心 主任

New Paradigm of Genomics Guided Clinical Trials to Develop Targeted Therapy: A Case Study with Attention Deficit and Hyperactivity

3:00pm-3:30pm

Emmanuelle VOISIN，法国Voisin公司 CEO

Regulation : clinical trials fields in Europe

3:50pm-4:20pm

Li Xing，美国辉瑞公司 高级主任研究员

Discovery of poten, selective and efficacious p38 MARK Inhibitor as clinical drug candidate

4:20pm-4:50pm

赵秀丽，首都医科大学附属北京同仁医院临床药理基地主任、国家药物机构检查员

 

4:50pm-5:20pm

Haibo Wu，中国医药生物协会理事，中国统筹法优选法与经济数学研究会统筹学分会常务理事

脑血管病创新药物的临床试验研究

分会6  主席：Cai Li，美国默克公司 体内药理部中国负责人  

9:00am-9:30am

德国勃林格殷格翰公司

 

9:30am-10:00am

Zhanglin Lin，清华大学化工系 工业酶国家工程实验室 副主任，中国微生物学会酶工程专业委员会 副主任

Recombinant production of peptides in Escherichia coli using cleavable self-aggregating tag (cSAT)

10:00am-10:30am

Liqiang Derek Tou，美国Taketa-Millennium 公司 研究员

An innovative room temperature sterilization equipment for Chinese market

10:45am-11:15am

Lijun Wang，美国Merck公司全球采购部 高级科学家

A Cost-Effective Method to Remove Palladium from Pharmaceutical Intermediates and APIs

11:15am-11:45am

 

分会7主席：Zhihong Chen，美国Eisai公司 首席科学家

9:00am-9:30am

Zhiyong Qiu，美国曼康公司 抗肿瘤产品研发部 副主任, 肿瘤免疫治疗首席科学家

Quest for durable disease control by induction of optimal effector T cells in cancer patients

9:30am-10:00am

Raman Rao，赛诺菲巴斯德公司外部研发部亚太区负责人

External Partnerships and Internal discovery for successful Vaccine Development

10:00am-10:30am

王义汉，美国Adiad公司  研发副总监

Recent Advances in Targeted Therapy for Oncology

10:45am-11:15am

Laura Hong，美国Merck公司 高级科学家

Challenges and Solutions for Maintaining Quality and Potency of the Product in Vaccine Development

11:15am-11:45am

Cedric Y. Szpirer，比利时Delphi Genetics公司 共同创始人

Use of bacterial selection genes to get higher yields and to remove antibiotic resistance genes in bioproductions

11:45am-12:15am

Sanjay D. Khare，美国ImmunGene公司 CEO

Empowered cytokine fused-antibodies to overcome limitations of first and second generation therapeutic antibodies

分会7   主席：Zhiyong Qiu，美国曼康公司 抗肿瘤产品研发部 副主任, 肿瘤免疫治疗

首席科学家  

2:00pm-2:30pm

Anna Cherouvrier Hansson，Head of Business Development Life Science, Invest in Skåne

Introducing cancer research excellence in Southern Sweden

Dan Mogren，Business Development Director, Lund Life Science Incubator

Ulrika Ringdahl，Chief Communication Officer

Lars-Erik Eriksson，Chief Executive Officer, Clinical Laser Thermia

2:30pm-3:00pm

Karolina Österlund，Manager Field Application Scientist EU and Asia, Gyros AB, Uppsala, Sweden

Automated Nanoliter Scaled Immunoassay Performed on a Compact Disc:  Maximizing productivity and efficiency in protein bioanalytics

3:00pm-3:30pm

Binhui Ni，Sanofi

Sanofi:A diversified global healthcare leader---Creating Value Through Partnership

3:50pm-4:20pm

William Cao，President, China Biotech Group Ltd

Patient-Specific Cancer Immunotherapy

4:20pm-4:50pm

Feng Li，健能隆医药技术（上海）有限公司  副总裁

Turning the global pharmaceutical industry challenges into development opportunities to grow China Biotech businesses – the case for Generon

分会 4 主席： David Wong，美国加州大学洛杉矶分校牙科学院副院长、

    牙科研究所主任

9:00am-9:30am

Carl A.K. Borrebaeck，瑞典Lund大学 副校长，免疫技术系教授、癌症转化研究战略中心创新健康计划负责人

Molecular portraits associated with improved prognosis and

diagnosis of cancer

9:30am-10:00am

David Wong，美国加州大学洛杉矶分校牙科学院副院长、牙科研究所主任

Saliva: The Emerging Diagnostic Frontier

10:00am-10:30am

Davide Bedognetti，美国国立卫生研究院临床中心传染病及免疫基因学部 主任助理、研究员

Biomarkers of immunoresponsiveness in cancer immunotherapy: hypothesis-driven and discovery-driven translational approaches

10:45am-11:15am

John Gu，美国新尚制药公司 董事总经理；美国国家癌症研究院 兼职教授

 

11:15am-11:45am

1. President, CEO and co-founder, AltraBio;      2. CTO

ALTRABIO – INTEGRATIVE ANALYSIS OF LIFE SCIENCE DATA

11:45am-12:15am

Yuxun Wang（或S3）美国Metamark Genetics公司 研发副总监

Integrate oncogenomics based anti-cancer drug target and biomarker

2:00pm-2:30pm

Achim Göpferich，德国雷根斯堡大学 药物化学系主任

Nanoparticle Interactions with Cell Surface Receptors: New Keys for Old locks

2:30pm-3:00pm

Shoufeng Li，美国 Novartis公司 技术项目总监

Recent advances in Pharmaceutics, Biopharmaceutics and Physiology Pharmaceutics

3:00pm-3:30pm

Michael F. Haller，美国Anaphore公司 战略合作副总裁 

Differentiating Biosimilars through Drug Delivery

3:50pm-4:20pm

Jerry Zhang，美国Shire公司  高级研发经理

Lipid Based Therapeutcis Nanoparticles

 

4:20pm-4:50pm

Steven Sun， 美国GeneWiz公司 总裁

 

2:00pm-2:30pm

Bai Chunxue，复旦大学附属中山医院呼吸科主任，上海呼吸病研究所主任

呼吸病患者的雾化吸入治疗

2:30pm-3:00pm

Song Yuanlin，复旦大学附属中山医院呼吸科副主任，上海呼吸病研究所副主任

雾化吸入治疗技术的进展

 

3:00pm-3:30pm

 

 

3:50pm-4:20pm

 

 

1:30pm-1:40pm

上海对外科学技术交流中心领导致辞

 

1:40pm-2:10pm

董树沛 上海市科学技术委员会生物医药处 副处长  

上海生物医药产业规划与布局

2:10pm-2:40pm

张清 上海市食品药品监督管理局 药品注册处 副处长

上海市药品注册管理的政策解读

2:40pm-3:10pm

徐国雄/李永忠/姜远英 上海医药集团股份有限公司（副）总裁

新形势下的医药产业发展

3:10pm-3:30pm

茶歇

 

3:30pm-4:10pm

沈竞康 中科院上海药物研究所研究员、博导、副所长

新形势下的医药产业发展的机遇和挑战

4:10pm-4:50pm

宁光  瑞金医院副院长、内分泌代谢科主任医师

 

4:50pm-5:30pm

毛振民 交通大学药学院教授

 

5:30pm-5:40pm

Q&A

 

6:00pm-7:00pm

招待晚宴

 

1:30pm-1:40pm

上海市科学技术委员会国际合作处领导致辞

 

1:40pm-2:10pm

王红强，联合利华大中华及东北亚区开放创新总监 

联合利华开放创新模式和生物技术领域的机遇

2:10pm-2:40pm

李林 联合利华研究科学家

中长多肽及多肽药物的高效制备技术

2:40pm-3:10pm

林旭 教授，中科院上海生命科学研究院营养科学研究所人类营养与疾病研究组组长

营养、遗传变异与慢性代谢性疾病的人群研究

3:10pm-3:30pm

茶歇

 

3:30pm-4:00pm

刘保延 教授，中国针灸学会会长

 

4:00pm-4:30pm

刘承宜 教授，华南师范大学激光运动医学实验室主任

鼻腔内低强度激光照射治疗：临床、基础与应用

4:30pm-5:00pm

东红升 副研究员 上海市针灸经络研究所

针灸对糖尿病及并发症的防治

5:00pm-5:30pm

Q&A

 

6:00pm-7:00pm

招待晚宴

 

● 标准套票

2400

会议资料，会议期间午餐，茶歇，晚宴, 赠送2张学生票。

● 团体预定(5人以上)

2200

● 学生套票

1200

会议资料，会议期间午餐，茶歇